表紙
市場調査レポート

動脈狭窄症:世界の治験レビュー

Artery Stenosis Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 315199
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
動脈狭窄症:世界の治験レビュー Artery Stenosis Global Clinical Trials Review, H1, 2015
出版日: 2015年04月28日 ページ情報: 英文 75 Pages
概要

当レポートでは、動脈狭窄症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 動脈狭窄症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域
    • 上位5ヶ国における治験件数; 中南米

G7諸国における治験件数: 動脈狭窄症 治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:動脈狭窄症 治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 動脈狭窄症治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • Abbott Laboratories
    • Bayer AG
    • AstraZeneca PLC
    • CardioVascular BioTherapeutics, Inc.
    • Bracco S.p.A.
    • Archemix Corp.
    • AMAG Pharmaceuticals, Inc.
    • advanceCor GmbH
  • 代表的な研究機関/病院の治験の概要
    • 岐阜大学医学部
    • Mayo Clinic
    • Asan Medical Center
    • Emory University
    • 岐阜大学
    • National Heart, Lung, and Blood Institute
    • University of Oxford
    • 旭川医科大学
    • Azienda Ospedaliera di Perugia
    • Azienda Ospedaliera S. Anna

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2650CTIDB

GlobalData's clinical trial report, "Artery Stenosis Global Clinical Trials Review, H1, 2015" provides data on the Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Artery Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Artery Stenosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Artery Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Artery Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Artery Stenosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Artery Stenosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • CardioVascular BioTherapeutics, Inc.
      • Clinical Trial Overview of CardioVascular BioTherapeutics, Inc.
      • Bracco S.p.A.
      • Clinical Trial Overview of Bracco S.p.A.
      • Archemix Corp.
      • Clinical Trial Overview of Archemix Corp.
      • AMAG Pharmaceuticals, Inc.
      • Clinical Trial Overview of AMAG Pharmaceuticals, Inc.
      • advanceCor GmbH
      • Clinical Trial Overview of advanceCor GmbH
    • Clinical Trial Overview of Top Institutes / Government
      • Gifu University School of Medicine
      • Clinical Trial Overview of Gifu University School of Medicine
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Emory University
      • Clinical Trial Overview of Emory University
      • Gifu University
      • Clinical Trial Overview of Gifu University
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Asahikawa Medical University Hospital
      • Clinical Trial Overview of Asahikawa Medical University Hospital
      • Azienda Ospedaliera di Perugia
      • Clinical Trial Overview of Azienda Ospedaliera di Perugia
      • Azienda Ospedaliera S. Anna
      • Clinical Trial Overview of Azienda Ospedaliera S. Anna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Artery Stenosis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Artery Stenosis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Artery Stenosis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco S.p.A., 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archemix Corp., 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AMAG Pharmaceuticals, Inc., 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by advanceCor GmbH, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University School of Medicine, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahikawa Medical University Hospital, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Perugia, 2015*
  • Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera S. Anna, 2015*

List of Figures

  • Artery Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Artery Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top